[February 27, 2015] |
|
Company Profile for Izun Pharmaceuticals Corporation
Izun Pharmaceuticals is a US based pharmaceutical company with a wholly
owned R&D center in Israel. Izun's technology platform allows it to
develop botanical drugs by optimizing and purifying the extracted
botanical compounds to yield polymolecular drug candidates. These
patented products are designed to impact on multiple specific receptor
targets. The main therapeutic focus is on agents that can reduce
inflammation and accelerate healing. Izun is currently active in
developing therapeutic products for a number of indications including:
oral care, oncology support, wound care, women's health care,
gastrointestinal disease and dermatologic conditions. Izun uses the
inherent advantage of the natural botanical sources to deliver robust
clinical results with an excellent safety profile. Izun has currently
received approval for a number of oral care products that are marketed.
Additional clinical studies are in progress for indications, including
diabetic foot ulcers and atrophic vaginitis.
|
Company:
|
|
Izun Pharmaceuticals Corporation
|
|
|
Headquarters Address:
|
|
One Rockefeller Plaza
|
|
|
|
11th floor
|
|
|
|
New York, NY 10003
|
|
|
Main Telephone:
|
|
2126186357
|
|
|
Website:
|
|
www.izunpharma.com
|
|
|
Type of Organization:
|
|
Private
|
|
|
Industry:
|
|
Health
|
|
|
Key Executives:
|
|
CEO: William Levine
|
|
|
|
Director: Elliot Hahn
|
|
|
|
CFO: Les Kraus
|
|
|
Customer Service
|
|
|
|
Contact:
|
|
Mordechai Levinson
|
|
Phone (News - Alert):
|
|
972-72-245-8950
|
|
Email:
|
|
[email protected]
|
[ Back To TMCnet.com's Homepage ]
|